News

Asianet Newsable on MSN39m

Sarepta Pauses Shipments Of DMD Drug Elevidys Amid FDA Label Review, Stock Tumbles After-Hours

H.C. Wainwright slashed its price target to $0, assigning a 'Sell' rating and saying Sarepta has no remaining intrinsic value ...
Stockhead on MSN55m

Health Check: Bug buster Genetic Signatures’ US expansion is a jumbo-sized task

Tummy bug testing outfit Genetic Signatures is honing its operations after finding its company-making US expansion was harder ...